Abstract
OBJECTIVE: To test the effect of low calorie diet (LCD) on body weight, lipid profile, and glycemic control in obese type 2 diabetes mellitus (DM) patients.
DESIGN: Dietary intervention.
SETTING: Department of Human Nutrition, Copenhagen.
SUBJECTS: Outpatients: 11 type 2 DM patients (three males/eight females) (10 completed), four on oral hypoglycemic agents (OHA). Body mass index (BMI) 36.8±5.5 kg/m2 and age 62±5.7 y.
INTERVENTIONS: In all, 8 weeks full meal-replacement diet: eight sachets of a nutrition powder (Nutrilett®, 850 kcal/day). Lipid profile assessed by NMR spectroscopy.
RESULTS: Mean body weight fell by 10.9 kg (∼11%, P<0.001). Fasting insulin, fasting blood glucose, hemoglobin A1c, fasting plasma triglycerides, total cholesterol, and low-density lipoprotein (LDL) cholesterol fell significantly. There were large positive changes (statistically insignificant) in LDL subclass distribution and a similar shift in high-density lipoprotein subclass distribution. Medication was discontinued in all four subjects taking OHA for 2 weeks prior to the intervention and throughout the whole 8-week intervention period.
CONCLUSION: LCD is effective in improving glycemic control and blood lipids through weight loss in overweight type 2 DM patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Steiner G . Dyslipoproteinemias in diabetes. Clin Invest Med 1995; 18: 282–287.
Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M . Mortality from coronary subjects with type 2 diabetes and in nondiabetic subjects with or without prior myocardial infarction. N Engl J Med 1998; 339: 229–234.
Henry RR, Wiest-Kent TA, Scheaffer L, Kolterman OG, Olefsky JM . Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes 1986; 35: 155–164.
Amatruda JM, Richeson JF, Welle SL, Brodows RG, Lockwood DH . The safety and efficacy of a controlled low-energy (‘very-low-calorie’) diet in the treatment of non-insulin-dependent diabetes and obesity. Arch Intern Med 1988; 148: 873–877.
Weck M, Hanefeld M, Schollberg K . Effects of VLCD in obese NIDDM (non-insulin dependent diabetes) on glucose, insulin and C-peptide dynamics. Int J Obes Relat Metab Disord 1989; 13: 159–160.
Anderson JW, Brinkman-Kaplan V, Hamilton CC, Logan JEB, Collins RW, Gustafson NJ . Food-containing hypocaloric diets are as effective as liquid-supplement diets for obese individuals with NIDDM. Diabetes Care 1994; 17: 602–604.
Capstick F, Brooks BA, Burns CM, Zilkens RR, Steinbeck KS, Yue DK . Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient. Diabetes Res Clin Pract 1997; 36: 105–111.
Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM . Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992; 38: 1632–1638.
Wolf HU, Lang W, Zander R . Alkaline haematin D-575, a new tool for the determination of haemoglobin as an alternative to the cyanhaemoglobin method II. Standardization of the method using pure cholorohaemin. Clin Chim Acta 1984; 136: 95–104.
Foster GD, Wadden TA, Peterson FJ, Letizia KA, Bartlett SJ, Conill AM . A controlled comparison of three very-low-calorie diets: effects on weight, body composition, and symptoms. Am J Clin Nutr 1992; 55: 811–817.
Miller NE . Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987; 113: 589–597.
Fievet C, Fruchart JC . HDL heterogeneity and coronary heart disease. Diabetes Metab Rev 1991; 7: 155–162.
Bakogianni MC, Kalofoutis CA, Skenderi KI, Kalofoutis AT . Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary heart disease. J Diabetes Complicat 2001; 15: 265–269.
Johansson J, Carlson LA, Landou C, Hamsten A . High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991; 11: 174–182.
Austin MA, Hokanson JE, Brunzell JD . Characterization of low-density lipoprotein subclasses: methodologic and clinical relevance. Curr Opin Lipidol 1994; 5: 395–403.
Laakso M, Lehto S, Penttilä I, Pyörälä K . Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993; 88: 1421–1430.
Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP . Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in man. Circulation 1997; 95: 69–75.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harder, H., Dinesen, B. & Astrup, A. The effect of a rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients. Int J Obes 28, 180–182 (2004). https://doi.org/10.1038/sj.ijo.0802529
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802529
Keywords
This article is cited by
-
The effect of diet-induced weight loss on circulating homocysteine levels in people with obesity and type 2 diabetes
Nutrition Journal (2024)
-
Effects of Bariatric Surgery on Sarcopenic Obesity Outcomes: A One-Year Prospective Study in Middle-Aged Women
Obesity Surgery (2024)
-
Body Composition Differences Between Excess Weight Loss ≥ 50% and < 50% at 12 Months Following Bariatric Surgery
Obesity Surgery (2022)
-
Immediate Metabolic Response Following Sleeve Gastrectomy in Obese Diabetics
Obesity Surgery (2015)
-
Change in Predicted 10-Year Cardiovascular Risk Following Roux-en-Y Gastric Bypass Surgery: Who Benefits?
Obesity Surgery (2011)